A recent study published in the New England Journal of Medicine concluded that the use of a wireless pill camera, like Given Imaging's PillCam, in its current generation, is not as effective as a ...

DUBLIN, Nov. 15, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance ...

The Food and Drug Administration has cleared the PillCam SB video capsule, including clearance to promote its use in monitoring lesions that may indicate Crohn’s disease, according to a Given Imaging ...

New studies show Given Imaging’s new PillCam SB can help detect lesions involved in Crohn’s disease and monitor disease progression in patients with suspected and known Crohn’s disease, according to a ...

If you're a fan of the television show House, you may have already heard of Israel-based Given Imaging's PillCam. However, Joshua Devine, a high school sophomore who lives near San Diego, became one ...

Given Imaging has announced it has filed an FDA application seeking regulatory clearance to market its PillCam COLON 2 for visualization of the lower gastrointestinal tract, according to a news ...

TEL AVIV, July 15 (Reuters) - Israeli camera-in-a-pill maker Given Imaging has received Japanese regulatory approval for its PillCam Colon video capsule for diagnosis of colonic disease when ...

Medtronic — known for making complicated medical devices that often require a surgeon to implant them — is partnering with Amazon.com to deliver pill-sized cameras to patients' doorsteps. At home, the ...

Given Imaging GIVN, a world leader in GI medical devices and pioneer of capsule endoscopy, today announced the initiation of and first PillCam COLON 2 capsule procedures in a large, multi-center, ...

The U.S. Food and Drug Administration has cleared Yoqneam, Israel-based Given Imaging’s PillCam COLON for use for patients after an incomplete optical colonoscopy, according to a Given Imaging news ...

PillCam COLON 2 received the CE Mark in September 2009 and is commercially available throughout Europe, Latin America, Canada, Australia and parts of Asia. A pivotal study is under way in the U.S.

A new 'PillCam' ingestible capsule might be a feasible alternative to conventional upper endoscopy for assessing patients with suspected esophageal disorders. A pilot study by Eliakim et al. has ...